HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California's Nonconforming Microbeads Bill Could Limit Viable Alternatives

This article was originally published in The Rose Sheet

Executive Summary

While industry has lobbied for uniformity in state legislation phasing out plastic microbeads in personal-care products, a bill is gaining steam in California that could bar manufacturers from adopting even biodegradable plastic alternatives due to a broader definition of targeted ingredients. Meanwhile, a House microbeads bill at the federal level has gained a companion in the Senate, but definitions are still unclear.

You may also be interested in...



In Brief: Federal Microbeads Bill Advances; Avon Buyout Hoax? More

The Microbead-Free Waters Act of 2015 was approved via voice vote by the House Energy and Commerce Health Subcommittee May14; Avon says it has not received a buyout offer from PTG Capital Partners despite a May 13 SEC filing from the firm indicating as much. More news in brief.

Regulatory News In Brief: House Microbeads Bill; Oregon Eyes Children’s Cosmetics; More

Rep. Frank Pallone, D-N.J., reintroduces his bill proposing a ban on personal-care products containing synthetic plastic microbeads; Oregon legislation would require ingredient reporting and reformulations from manufacturers of children’s cosmetics containing flagged chemicals. More regulatory news.

EU Motivated Like Never Before To Advance Non-Animal Methods For Chemical Assessment

Lack of validated, regulatory-accepted methods for evaluating complex chemical safety endpoints without animal testing is quickly becoming a problem for industries and stakeholders beyond the cosmetics sector. Momentum is building to drive alternatives development as European authorities set their sights on an animal-free chemicals assessment future.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel